Meregaglia, Michela http://orcid.org/0000-0003-0092-5970
Malandrini, Francesco
Finch, Aureliano Paolo
Ciani, Oriana
Jommi, Claudio
Funding for this research was provided by:
EuroQol Research Foundation (20190460)
AbbVie Italia
Fondazione Smith Kline
Merck Sharp and Dohme Italia
Roche Italia
Sanofi Italia
Università Commerciale Luigi Bocconi
Article History
Accepted: 31 October 2022
First Online: 25 November 2022
Declarations
:
: The data collection for this study was supported by unconditional grants from the EuroQol Research Foundation, AbbVie Italy, Fondazione SmithKline, Merck Sharp & Dohme Italy, Roche Italy, and Sanofi Italy.
: Aureliano Paolo Finch is a member of the EuroQol Group and is employed by the EuroQol Office. Michela Meregaglia, Francesco Malandrini, Oriana Ciani, and Claudio Jommi have no competing interests to declare that are relevant to the contents of this article.
: This study was approved by the Ethics Committee of Bocconi University on 6 October 2020 (approval number: 2020-SA000136.4).
: Consent to participate was obtained by the market research company prior to scheduling the interview.
: Not applicable.
: The data set supporting the conclusions of this study may be available upon reasonable request.
: Not applicable.
: MM, APF, OC and CJ conceived and designed the study. All authors carried out the data collection with the support of a market research company and a team of interviewers. MM and FM analysed the data, and all authors contributed to the interpretation of the findings. MM drafted the first manuscript version and all authors commented on this version. All authors read and approved the final manuscript.